Bellevue Group’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-166,355
Closed -$40.9M 183
2022
Q3
$40.9M Sell
166,355
-3,154
-2% -$852K 0.59% 51
2022
Q2
$42M Buy
169,509
+19,331
+13% +$5.22M 0.59% 53
2022
Q1
$49.7M Hold
150,178
0.58% 58
2021
Q4
$53.9M Sell
150,178
-1,000
-0.7% -$338K 0.56% 62
2021
Q3
$49.2M Hold
151,178
0.5% 64
2021
Q2
$47.2M Buy
151,178
+8,494
+6% +$2.61M 0.46% 68
2021
Q1
$45.5M Buy
142,684
+35,127
+33% +$11.2M 0.48% 67
2020
Q4
$34.9M Buy
107,557
+6,159
+6% +$1.7M 0.4% 72
2020
Q3
$28.1M Buy
101,398
+4,699
+5% +$1.35M 0.39% 71
2020
Q2
$23.4M Sell
96,699
-11,373
-11% -$2.28M 0.33% 72
2020
Q1
$15.7M Buy
108,072
+20,233
+23% +$3.36M 0.3% 67
2019
Q4
$15M Sell
87,839
-45,192
-34% -$8.38M 0.24% 74
2019
Q3
$23.7M Sell
133,031
-1,651
-1% -$357K 0.44% 52
2019
Q2
$35.1M Buy
134,682
+75,293
+127% +$20M 0.6% 44
2019
Q1
$17M Buy
59,389
+20,567
+53% +$6.84M 0.93% 34
2018
Q4
$12.6M Buy
38,822
+5,687
+17% +$1.98M 0.87% 37
2018
Q3
$14.9M Buy
33,135
+6,054
+22% +$2.39M 0.95% 36
2018
Q2
$11.1M Sell
27,081
-169
-0.6% -$61.2K 0.94% 40
2018
Q1
$7.93M Buy
27,250
+250
+0.9% +$63.4K 0.79% 49
2017
Q4
$5.06M Sell
27,000
-58,110
-68% -$10.8M 0.53% 48
2017
Q3
$14.3M Buy
85,110
+1,140
+1% +$172K 1.5% 19
2017
Q2
$12M Buy
83,970
+20,300
+32% +$2.73M 1.42% 23
2017
Q1
$7.97M Buy
63,670
+18,620
+41% +$2.16M 1.06% 37
2016
Q4
$5.08M Sell
45,050
-10,400
-19% -$1.2M 1.04% 31
2016
Q3
$7.13M Sell
55,450
-1,750
-3% -$210K 1.29% 28
2016
Q2
$6.25M Buy
+57,200
New +$5.69M 1.18% 28

Other funds holding ABMD